BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 35993054)

  • 1. Identification of Potential Prognostic Biomarkers Associated with Monocyte Infiltration in Lung Squamous Cell Carcinoma.
    Liu H; Yan B; Chen Y; Pang J; Li Y; Zhang Z; Li C; Qin T
    Biomed Res Int; 2022; 2022():6860510. PubMed ID: 35993054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. POLE2 Serves as a Prognostic Biomarker and Is Associated with Immune Infiltration in Squamous Cell Lung Cancer.
    Wu Z; Wang YM; Dai Y; Chen LA
    Med Sci Monit; 2020 Apr; 26():e921430. PubMed ID: 32304567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer.
    Liu X; Liu X; Li J; Ren F
    Med Sci Monit; 2019 Dec; 25():9280-9289. PubMed ID: 31805030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated bioinformatics combined with machine learning to analyze shared biomarkers and pathways in psoriasis and cervical squamous cell carcinoma.
    Liu L; Yin P; Yang R; Zhang G; Wu C; Zheng Y; Wu S; Liu M
    Front Immunol; 2024; 15():1351908. PubMed ID: 38863714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and validation of key genes associated with non-small-cell lung cancer.
    Ma Q; Xu Y; Liao H; Cai Y; Xu L; Xiao D; Liu C; Pu W; Zhong X; Guo X
    J Cell Physiol; 2019 Dec; 234(12):22742-22752. PubMed ID: 31127628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genes whose expressions in the primary lung squamous cell carcinoma are able to accurately predict the progression of metastasis through lymphatic system, inferred from a bioinformatics analyses.
    Khashei Varnamkhasti K; Moghanibashi M; Naeimi S
    Sci Rep; 2023 Apr; 13(1):6733. PubMed ID: 37185598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis.
    Wang L; Qu J; Liang Y; Zhao D; Rehman FU; Qin K; Zhang X
    Thorac Cancer; 2020 Apr; 11(4):851-866. PubMed ID: 32059076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying the hub genes in non-small cell lung cancer by integrated bioinformatics methods and analyzing the prognostic values.
    Wang T; Chen X; Jing F; Li Z; Tan H; Luo Y; Shi H
    Pathol Res Pract; 2021 Dec; 228():153654. PubMed ID: 34749208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Four hub genes regulate tumor infiltration by immune cells, antitumor immunity in the tumor microenvironment, and survival outcomes in lung squamous cell carcinoma patients.
    Zhang T; Yang H; Sun B; Yao F
    Aging (Albany NY); 2021 Jan; 13(3):3819-3842. PubMed ID: 33428598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Expression of
    Deng H; Huang Y; Wang L; Chen M
    Biomed Res Int; 2020; 2020():2071593. PubMed ID: 33134373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of Hub Genes and Infiltrating Immune Cells in Non-Smoking Females with Lung Adenocarcinoma by Integrated Bioinformatic Analysis.
    Li J; Wang B; Li X; Zhu Y
    Med Sci Monit; 2020 Jul; 26():e922680. PubMed ID: 32669531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential protein-coding gene and long noncoding RNA expression in smoking-related lung squamous cell carcinoma.
    Li S; Sun X; Miao S; Liu J; Jiao W
    Thorac Cancer; 2017 Nov; 8(6):672-681. PubMed ID: 28949095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of key microRNAs and hub genes in non-small-cell lung cancer using integrative bioinformatics and functional analyses.
    Song F; Xuan Z; Yang X; Ye X; Pan Z; Fang Q
    J Cell Biochem; 2020 Mar; 121(3):2690-2703. PubMed ID: 31692035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of differentially expressed genes between lung adenocarcinoma and lung squamous cell carcinoma by gene expression profiling.
    Lu C; Chen H; Shan Z; Yang L
    Mol Med Rep; 2016 Aug; 14(2):1483-90. PubMed ID: 27356570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Novel Biomarkers Related to Lung Squamous Cell Carcinoma Using Integrated Bioinformatics Analysis.
    Wang H; Huang L; Chen L; Ji J; Zheng Y; Wang Z
    Comput Math Methods Med; 2021; 2021():9059116. PubMed ID: 34659450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Key Biomarkers and Potential Molecular Mechanisms in Oral Squamous Cell Carcinoma by Bioinformatics Analysis.
    Yang B; Dong K; Guo P; Guo P; Jie G; Zhang G; Li T
    J Comput Biol; 2020 Jan; 27(1):40-54. PubMed ID: 31424263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and Integrate Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer Based on Bioinformatics Analysis.
    Gong K; Zhou H; Liu H; Xie T; Luo Y; Guo H; Chen J; Tan Z; Yang Y; Xie L
    Technol Cancer Res Treat; 2021; 20():15330338211060202. PubMed ID: 34825846
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of target gene and prognostic evaluation for lung adenocarcinoma using gene expression meta-analysis, network analysis and neural network algorithms.
    Selvaraj G; Kaliamurthi S; Kaushik AC; Khan A; Wei YK; Cho WC; Gu K; Wei DQ
    J Biomed Inform; 2018 Oct; 86():120-134. PubMed ID: 30195659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification for Exploring Underlying Pathogenesis and Therapy Strategy of Oral Squamous Cell Carcinoma by Bioinformatics Analysis.
    Xu Z; Jiang P; He S
    Med Sci Monit; 2019 Dec; 25():9216-9226. PubMed ID: 31794546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.